Corrigendum to “ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway” [Cancer Lett. 454 (2019) 179–190]
Titel:
Corrigendum to “ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway” [Cancer Lett. 454 (2019) 179–190]
Auteur:
Li, Yan Tao, Lei Zuo, Zeping Zhou, Yang Qian, Xinying Lin, Yiyun Jie, Hui Liu, Chunqi Li, Zhuoling Zhang, Huaqin Zhang, Hu Cen, Xiaobo Yang, Shengyong Zhao, Yinglan